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The in vitro assembly of a soluble protein into its mature
fibrillar form is usually accompanied by loss of its functional
activity.Our study is the first demonstrationof a natural enzyme
(HylP2) retaining its enzymatic activity on conversion frompre-
fibril to mature fibril and supports the contention that minor
conformational changes in the native folded form of a protein
can lead to the formation of a functional fibril. Hyaluronate
lyase (HylP2) is a natural enzyme of bacteriophage 10403 of
Streptococcus pyogenes.AtpH5.0, the enzymeundergoes partial
unfolding localized in its N-terminal domainwhile the C-termi-
nal domain maintains its folded trimeric conformation. This
structural variant ofHylP2 retains about 70% enzymatic activity
with hyaluronan. It further self-assembles into a fibrillar film in
vitro through solvent-exposed nonpolar surfaces and intermo-
lecular-sheet formation by the-strands in the protein. Inter-
estingly, the mature fibrillar film of HylP2 also retains about 60
and 20% enzymatic activity for hyaluronic acid and chondroitin
sulfate, respectively. The possession of broad substrate specific-
ity by the fibrillar form of HylP2 indicates that fluctuations in
pH, which do not lead to loss of functionality of HylP2, might
assist in bacterial pathogenesis. The formation of fibrillar film-
like structure has been observed for the first time among the
hyaluronidase enzymes. After acquiring this film-like structure
in bacteriophage, HylP2 still retains its enzymatic activity,
which establishes that these fibrils are a genuinely acquired pro-
tein fold/structure.
The phenomenon of transformation of proteins into fibrils is
of interest because extracellular fibrillar protein deposits or
amyloid plaques are characteristics of a group of neurodegen-
erative diseases such as Alzheimer disease and Parkinson dis-
ease, as well as many rare systemic diseases such as familial
amyloid polyneuropathy (1). Despite a lack of identifiable com-
mon features in the sequences and structures of the proteins
implicated in the different amyloid diseases, the fibrillar aggre-
gates associatedwith themare characterized by a high degree of
structural order and a high intermolecular -sheet content (2,
3). It has therefore been postulated that there is a common
underlying mechanism of formation of the various fibrillar
aggregates (4).
It is widely recognized that fibril formation in globular pro-
teins generally requires the presence of a partially unfolded
state, referred to as the “amyloidogenic intermediate” (5–8).
This can be a conformational state stable at equilibrium, arising
as a result ofmutations or changes of solution conditions (pHor
ionic strength etc.), a partially folded state accumulating tran-
siently before the major free-energy barrier for folding, or one
or more conformations resulting from structural fluctuations
within the native-state ensemble (9, 10). The requirement of a
partially unfolded state is because of the fact that the conforma-
tional rearrangements leading to the cross--structure cannot
take place in a packed folded conformation; a somewhat
unfolded conformational state, in which some of the amide and
carbon groups and hydrophobic moieties become accessible,
can easily enable the specific intermolecular interactions that
are necessary for amyloid aggregation to occur (6, 9, 11).
Numerous reports on the loss of biological activity of pro-
teins on the formation of proto-fibrils from native protein
forms and fibrils from proto-fibrillar forms have been stated
(12, 13). Fibrillation in nonpathological proteins leads to loss of
their biological function, whereas pathological proteins acquire
toxicity in proto-fibrillar forms (14–16). To date, the presence
of enzymatic activity in mature fibrils of any protein has not
been reported. However, functionally active amyloid-like fibrils
of a designed RNase A have recently been reported (17). In
addition to being present in the microorganisms, there is a nat-
urally occurring functional amyloid in mammals (Pmel17) that
functions as a template for the polymerization of melanin mol-
ecules in the melanosome (18), and thus strengthens the view
that fibrillar structures could rather be a selected protein fold in
the evolution of functional protein structures. These contradic-
tory findings then raised the need to address an important
question pertaining to fibrillar structure that whether native-
like structural domains undergo conformational modification
or they simply refold on fibril formation.
The hylP2 gene of bacteriophage 10403 of Streptococcus pyo-
genes encodes an enzyme hyaluronate lyase (HylP2)3 whose pri-
mary function is to degrade hyaluronan of the bacterial capsule
(19).We carried out biophysical characterization (20) and x-ray
data analysis of HylP2 (Protein Data Bank code 2DP5), which
demonstrated that the C-terminal domain of the protein pre-
dominantly consisted of -sheets harboring the active site res-
idues (20). To date there is no report on the presence of amy-
loid-like fibrillar structures in the bacteriophage of S. pyogenes,
* The costs of publication of this articlewere defrayed in part by the payment
of page charges. This article must therefore be hereby marked “advertise-
ment” in accordancewith 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by the Council of Scientific and Industrial Research, New Delhi,
India.
2 To whom correspondence should be addressed: Division of Molecular and
Structural Biology, Central Drug Research Institute, Lucknow 226001,
India. Fax: 91-522-223405; E-mail: bhakuniv@rediffmail.com.
3 The abbreviations used are: HylP2, hyaluronate lyase; ThT, thioflavin T; CR,
Congo red; ANS, 1-anilino-8-N-naphthalenesulfonic acid; HA, hyaluronic
acid; CS, chondroitin sulfate.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 284, NO. 8, pp. 5240–5249, February 20, 2009
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
5240 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 8•FEBRUARY 20, 2009
 by guest, on August 12, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
although the bacterium itself has been reported to possess amy-
loid-like M proteins on its surface, which help in spreading
bacterial infection by facilitating the attachment of this Gram-
positive bacterium to host soft tissues (21).
Our work, for the first time, highlights the transformation of
a functional, natively folded and nonfibrillar natural enzyme
(HylP2) into fibril- like structures that appear as a thin mem-
brane. This form of protein is different inmorphology from the
disease-causing fibrils known to date, and the presence of enzy-
matic activity in such structures provides indications toward
their plausible role in the biology of the organism. In bacteri-
ophage, these structures can be considered to assist in phage
access into the bacterial cells even under stress conditions
(altered pH).
EXPERIMENTAL PROCEDURES
Materials
Escherichia coli DH5 cells were used during the cloning of
the gene. pET21d() vector (Novagen) and BL21 (DE3) cells
(Novagen) were used for protein expression.
Methods
Cloning, Overexpression, and Purification of Full-length
HylP2—The cloning, overexpression, and purification of full-
length HylP2 was performed as described earlier (20).
Fibril Formation in HylP2—A stock (1 mM) solution of ThT
(thioflavin T) was prepared by dissolving ThT in double dis-
tilled water. ThT was stored at 4 °C and protected from sun-
light. Fresh solutions of ThT were passed through a 0.2-m
filter immediately before use. HylP2 at a concentration of 1
mg/ml was dialyzed in buffer containing 10 mM citrate glycine/
HEPES (CGH), 150mMNa2SO4 (sodium sulfate), and 10% glyc-
erol at different pH values. The dialysis was carried out at 4 °C
for 14 h. Aliquots were taken at desired time intervals for con-
ducting the pH-related experiments.
Size-exclusion Chromatography—Gel filtration experiments
were carried out on a Superdex 200 HR 10/300 column (man-
ufacturer’s exclusion limit 600 kDa) with AKTA fast perform-
ance liquid chromatography (AmershamBiosciences). The col-
umn was equilibrated and run with 10 mM CGH, 150 mM
sodium sulfate, and 10% glycerol (at desired pH values). 200 l
(containing at least 0.2mg protein) of the sample was loaded on
the column and run at 25 °C at a flow rate of 0.3 ml/min, and
eluted protein was detected at 280 nm.
Fluorescence Measurements—Fluorescence spectra were
recorded with a PerkinElmer Life Sciences LS 50B spectroflu-
orometer in a 5-mm path length quartz cell at 25 °C. For tryp-
tophan fluorescence, excitation wavelength of 290 nm was
used, and the spectra were recorded between 300 and 400 nm
using 1 M of HylP2 for the studies. For ANS binding studies,
excitation wavelength was 350 nm, and the emission spectra
were recorded between 400 and 500 nm. The final concentra-
tion of ANS used for the experiments was 10 M. 5 M aliquots
of the dialyzing samples were added to a solution containing
ANS in the dialyzing buffer at pH 5.0 and mixed for 2 min
before measuring the fluorescence emission. Background
absorption of the buffer for the native HylP2 was subtracted
from each reading. All the readings were taken in triplicate.
CD Measurements—CD measurements were made with a
Jasco J810 spectropolarimeter. The results were expressed as
mean residual ellipticity [], which is defined as []  100 
obs/(lc), where obs is the observed ellipticity in degree; c is the
concentration inmoles of residue/liter; and l is the length of the
light path in centimeter. Each spectrum was an average of two
scans. The values obtained were normalized by subtracting the
base line recorded for the buffer under similar conditions. Spec-
tra were recorded using 3 M HylP2 in 1-mm cell, with 1 mM
CGH, 150 mM sodium sulfate, 10% glycerol, at different pH
values. All scans were made in the far UV region, i.e. between
200 and 250 nm.
Activity Assay—The in vitro activity assay for HylP2 was per-
formed using hyaluronic acid (HA) and chondroitin sulfate
(CS) as substrates. The activity of the enzyme was determined
by measuring its ability to breakdownHA or CS to unsaturated
disaccharide units (22). In 1 ml of solution having 0.3 mg/ml
HA/CS (or mentioned otherwise), 50 mM sodium acetate
buffer, 20mM calcium chloride (pH 6.0), and 2g of full-length
native HylP2 at pH 7.0 or the fibrillar form of HylP2 at pH 5.0
(diluted just before taking measurement) was added. The reac-
tants were properlymixed immediately, and themeasurements
were carried out by monitoring the increase in absorbance at
232 nm for 200 s at 37 °C. Varying concentrations of HA and
CS, between 0.003 and 0.3 mg/ml, were used for kinetic meas-
urements. The kinetic parameterswere calculated using extinc-
tion coefficient of 5.5  103 M1 for the disaccharide prod-
ucts. The readings were taken in triplicate, and percentage
error was calculated.
Transmission Electron Microscopy—HylP2 at a concentra-
tion of 1 mg/ml at pH 7.0 and pH 5.0 was diluted 20 times in
CGH buffer of pH 7.0 and pH 5.0, placed onto carbon-coated
grids, and allowed to adsorb for 4 min. After 5 min, the excess
liquid at the edge of the grid was removed with the help of filter
paper. The grid was negatively stainedwith 1% uranyl acetate at
pH 7.0 and 5.0 (as required) and air-dried after removing the
excess stain. After incubating the gridwith dye for 5min, excess
of solution was removed with the help of a filter paper, and the
grid was left to dry at room temperature. The grid was then
stored in an electronmicroscope grid box prior to examination.
The specimens were viewed, and images were recorded at 80 or
120 kVwith an FEI Technai Twin transmission electronmicro-
scope equipped with a mega view II CCD camera. Image acqui-
sition and analysis were carried out with analysis software. Low
magnification (10,000–12,000) was used to get an idea of the
overall sample composition, and a higher magnification
(25,000) was also used to obtain the sheet-like morphology.
Fluorescence Microscopy—For fluorescence imaging, a Zeiss
Axiovert 200 M microscope equipped with an -Plan-Fluar
100/1.45 numerical aperture oil immersion objective was used
with FluoArc (Zeiss) as light source. Images were captured on
1.4-mega-pixel Zeiss CCD camera AxioCam HRm. Images
were acquired and processed using software Axiovision
AxioVs40 version 4.4.0.0. For TIRF imaging, TIRF slider cou-
pled with argon ion laser (Lasos, Lasertechnik GmbH, Jena,
Germany). 10 l of HylP2 at pH 7.0 and pH 5.0 at 0.6–1 mg/ml
was taken and stained with 2l of thioflavin T. The sample was
placed on a glass slide, and the image was recorded.
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ThT Assay for Determining Kinetics of Fibrillation—Free
ThT has excitation and emission maxima at 350 and 450 nm,
respectively. However, upon binding to fibrils the excitation
and emission max changed to 450 and 480 nm, respectively
(23). 5 M aliquots of the HylP2 at pH 7.0 and dialyzed samples
of full-lengthHylP2 at pH 5.0 were added to a solution contain-
ing 10 M ThT in the dialyzing buffer at pH 5.0 and pH 7.0,
respectively, and shaken for 5 min before measuring the fluo-
rescence emission on a PerkinElmer Life Sciences LS 50B spec-
trofluorometer in a 5-mm path length quartz cell at 25 °C. A
background fluorescence spectrum obtained by running a
blank buffer with ThT was subtracted from each sample fluo-
rescence spectrum. The excitationwavelengthwas 450 nm, and
the emission was recorded at 480 nm. Fluorescence intensity at
480 nm was plotted against time for analysis. All readings were
taken in triplicate, and the error bar between them was
calculated.
Congo Red Binding—Fresh solutions of Congo red (CR) in 10
mMCGH, 150mM sodium sulfate (pH 7.0) were passed through
a 0.2-m filter immediately before use. The CR solutions were
added to 5M of protein solutions (dialyzed at pH 5.0) to a final
dye concentration of 10M, and the sampleswere incubated for
2 min. The absorption spectrum of each sample was recorded
from 400 to 700 nm on a PerkinElmer Life Sciences UV-visible
spectrophotometer using 1-cm path length quartz cuvette and
corrected for contributions of buffer andprotein. The spectrum
of CR alone was compared with that of CR solutions in the
presence of protein. Prior to addition of protein, the dye
absorbed at 490 nm, and after binding to fibrillar structures a
red shift of the absorption band toward 540 nm was observed
(24). Red shift togetherwith an increase in absorptionwas taken
to be indicative of the formation of fibrillar structures. Readings
were recorded in duplicate protein samples.
Fibril Purification—After dialyzing the native protein into
CGHbuffer (pH 5.0), the sample was ultracentrifuged at 80,000
rpm for 2 h in a Beckman Coulter Optima TL-X ultracentrifug-
ing system using a TLA 100 rotor. The supernatant was subse-
quently removed, and the fibril pellet was resuspended in min-
imal CGH buffer.
Limited Proteolysis—HylP2 protein at pH 7.0 and HylP2
fibrillar film at pH5.0were subjected to limited proteolysis with
-chymotrypsin in protease to protein ratio of 1:500 (w/w), for
2 h, at 30 °C. The protease reaction was stopped by adding pro-
tease inhibitor EDTA/phenylmethylsulfonyl fluoride to a final
concentration of 2mM in the reactionmixture, and the samples
were analyzed on 12% SDS-PAGE. For proteolysis of HylP2 at
pH 7.0 and fibrillar film at pH 5.0, proteinase K was used at
protein to protease ratio of 100:1 (w/w) for 8–10 h at 30 °C. The
reaction was stopped by adding phenylmethylsulfonyl fluoride,
and the proteolyzed samples were analyzed on 12% SDS-PAGE.
RESULTS ANDDISCUSSION
HylP2 is an110-kDa homotrimeric,/ protein (20) that is
devoid of disulfide bonds in its native folded state in the physi-
ological medium. The first few residues from the N-terminal
region of HylP2 are an / cap-like segment that is followed by
-helical coiled coils to residue 108. This flexible domain pro-
ceeds into a highly -rich C-terminal portion of the protein
consisting of 13 parallel -sheets arranged perpendicular to the
axis of the protein (Fig. 1A). The last few residues at the C
terminus again taper as -helical coils that do not interdigitate
as helical coils of the N-terminal portion of HylP2.4
pH-inducedModification in Structural Properties of HylP
pH and salts influence the electrostatic interactions in
natively folded proteins and thereby significantly affect the
structure, stability, and function of proteins (25). With the aim
to probe pH-induced alterations on HylP2, we subjected the
protein to pH changes. pH-dependent changes in secondary
and tertiary structures of HylP2 were studied using far-UV-CD
and tryptophan fluorescence spectroscopy, respectively, and
the results are summarized in Fig. 2A. The far-UV-CD spec-
trum shows a negative band centered around 218 nm suggest-
ing the existence of an extended-sheet conformation inHylP2
at pH 7.0. The intensity of the negative ellipticity band remains
steady in pH range from 7.0 to 10.0 suggesting that there is no
significant alteration in the secondary structure of the enzyme.
However, a slight change (maximum of 15%) in the secondary
structure of the enzyme was observed below pH 7.0, suggesting
that the secondary structure of HylP2 is significantly resistant
to fluctuations in pH.
The changes in tertiary structure ofHylP2 as a function of pH
were studied, and the results are presented in the Fig. 2B.
BecauseHylP2 had a single tryptophan residue at the 19th posi-
tion in its primary amino acid sequence, which corresponded to
the N-terminal region of HylP2 (Fig. 1A), any change in the
fluorescence emission maximum of this tryptophan residue
could be correlated only with the folding or unfolding of the
N-terminal region of HylP2. Under physiological conditions
(pH 7.0), this tryptophan moiety is buried in the hydrophobic
environment as the N-terminal region of the enzyme is in
folded conformation (20). The intrinsic fluorescence spectra of
the protein showed no significant differences for the wave-
length of maximum emission (max  330 nm), whereas on
decreasing the pH from 7.0 to 4.0, a noticeable sigmoidal
enhancement from 328 to 340 nm in the emission wavelength
was observed. The buried tryptophan residues in all folded pro-
teins show fluorescence emissionmaxima between 330 and 335
nm, whereas proteins in unfolded conformation show fluores-
cence emission maxima at about 350 nm (26). The red shift of
the max value from 328 to 340 nm at acidic pH conditions
suggested that under these conditions the tryptophan moiety
present in the enzyme was partially exposed to the hydrophilic
solvent because of partial unfolding of the N-terminal domain.
The studies presented above suggested that with fluctuations in
pH (pH6.0), HylP2 probably undergoes a single conformational
transition where the native-like protein was converted into a qua-
si-native state having a slightly disorganized N-terminal domain
and a native-like C-terminal domain architecture of protein.
To confirm the existence of partially unfolded species with
solvent-exposed hydrophobic clusters, we performed pH-de-
pendent ANS binding studies on HylP2. ANS is a hydrophobic
dye that binds to solvent-exposed hydrophobic surfaces of a
4 P. Mishra, V. Bhakuni, R. Prem Kumar, N. Singh, S. Sharma, P. Kaur, and T. P.
Singh, unpublished data.
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polypeptide chain. In a native folded protein the hydrophobic
amino acids were buried in the core of the protein, and ANS
binding is not observed; hence, the emission wavelength maxi-
mum of free dye is observed to be at 514 nm (Fig. 2B, inset).
However, on partial unfolding of the protein, ANS shows bind-
ing to the solvent-exposed hydro-
phobic amino acids, which led to a
shift in the fluorescence emission
maximum of the dye to 465 nm
accompanied by an enhancement in
the fluorescence intensity (27–29).
We monitored the affinity of pro-
tein for ANS binding at 465 nm as a
function of pH. As observed in Fig.
2B, between pH 10.0 and 6.0, the
increase in the fluorescence emis-
sion intensity of ANSwas negligible.
However, on decreasing the pH
from6.0 to 4.0, a large enhancement
(about four times) in the ANS fluo-
rescence intensity was observed.
This suggested that although the
hydrophobic regions of the enzyme
remained encompassed in the core
of HylP2 in the alkaline and physio-
logical pH range, thereby not allow-
ing the ANS molecules to bind to
them, acidic conditions caused the
exposure of hydrophobic patches
in the enzyme because of the
unfolding of the protein. Hence,
the tryptophan and ANS fluores-
cence studies together reaffirmed
that subjecting the protein to
acidic conditions led to the stabi-
lization of a partially folded inter-
mediate of HylP2.
Modifications in the quaternary
structure were also monitored
under pH conditions that were sta-
bilizing the partially unfolded spe-
cies of HylP2. Size-exclusion chro-
matography studies were then
carried out at different pH values,
and the results are shown in Fig. 2C.
HylP2 at pH 7.0 had a retention vol-
ume of 13.07 ml, which corre-
sponded to a molecular mass of
about 110 kDa, which corresponded
to the trimeric conformation of the
protein.However, on decreasing the
pH to 5.0 and below, a retention vol-
ume of 8.30 ml was observed that
corresponded to the void volume of
the gel filtration column and a
molecular mass of about 600 kDa or
more for the protein. This suggested
that under acidic conditions, HylP2
underwent significant enhancement in its hydrodynamic radii
probably because of aggregation of the enzyme. This was finally
confirmed by glutaraldehyde cross-linking. At pH 5.0, the
cross-linked protein sample did not even enter the well in SDS-
PAGE (Fig. 2D), which suggested that the cross-linked protein
FIGURE 1. The three-dimensional structure of HylP2.A, completemolecular stereo view showing the intertwin-
ing polypeptide chains colored in yellow, red, and green that represent its homotrimeric configuration. The distinct
domain topology can be seen with the N-terminal domain showing an -helical coiled segment extending from
residue 1 to 108 and the -rich groove of C-terminal from residue 121 to 297. The structure has been generated
using PyMOL. The x-ray crystal structure of HylP2 has been submitted by P. Mishra, V. Bhakuni, R. Prem Kumar, N.
Singh, S. Sharma, P. Kaur, and T. P. Singh (ProteinData Bank code 2DP5). This protein bears90% identity toHylP1
(Protein Data Bank code 2C3F). The structural details related to 2C3F have been published by Smith et al. (44).
B,ClustalWofHylP2withHylP1.C,zoomed imageof theN-terminal regionofHylP2showingthetryptophanresidue
at position 19th in all the three chains of HylP2. The image is created using PyMOL.
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had a very large molecular weight that was possible only when
the protein was aggregated under these conditions.
Overall the analysis presented here indicated that HylP2
populated under aggregating conditions (pH 5.0) had a partially
unfolded N-terminal domain and a folded C-terminal domain
indistinguishable from the native protein, and with time these
protein molecules coalesced into a HylP2 aggregate form.
Characterization of Aggregates of HylP2 Formed under Acidic
Conditions
DyeBinding—Toassess the existence of fibrous texture in the
aggregates of HylP2 formed at low pH (pH 5.0 and below), their
tinctorial and ultrastructural properties were examined. The
aggregates of HylP2 were characterized bymonitoring its bind-
ing to thioflavin T and Congo red dyes and then morphologi-
cally analyzed by transmission electron microscopy.
Congo red, a diazo dye, is widely used to identify fibrils
because it binds preferentially to the ordered, aggregated form
of peptides/proteins but does not bind to their native unas-
sembled forms (24, 30). We carried out Congo red binding to
HylP2 to identify the existence of fibril-like features in the
aggregates ofHylP2 stabilized at pH5.0. Fig. 3A shows the effect
of binding of Congo red (toHylP2 dialyzed at pH7.0 and 5.0) on
the absorption spectra of the dye. Binding of Congo red to pro-
teins is detected as a red shift in its absorbance spectrum from
490 to 520 nm. For the enzyme at pH 7.0, no shift in the absorp-
tion maximum and absorption intensity of the dye was
observed. However, on incubation of the enzyme at pH 5.0 with
Congo red, a red shift of about 20 nm in the absorptionmaxima,
i.e. from 490 to 510 nm, of the dye was observed. Such a prom-
inent red shift in the absorption maxima was attributed to the
strong intercalation of the dye into the ordered, intermolecular
-pleated sheet structure of the HylP2 fibrils. Hence, this indi-
cated that the aggregates of HylP2 formed at pH 5.0 had fibril-
like characteristics. An increase in the absorption intensity at
510 nm of HylP2 at pH 5.0 suggested a decrease in the native
form of the protein and an increase in the population of fibrillar
species, respectively.
ThT is a fluorescent dye and is known to bind to the linear
array of-strands in the amyloid fibrils. An enhancement in the
fluorescence emission intensity of ThT on binding to ordered
aggregates of protein is one of the most accepted methods to
show the presence of fibril formation (23, 31) under a given
condition. Fig. 3B shows the changes in emission intensity of
ThT at 480 nm on binding to HylP2 at pH 7.0 and 5.0. For
enzyme at pH 7.0, the fluorescence intensity was similar to that
shown for ThT alone suggesting that the dye does not bind to
native HylP2. However, for the enzyme at pH 5.0, an emission
spectrum having significantly high fluorescence intensity
(about 20 times) centered at about 480 nm was observed. This
demonstrated that ThT binds to the HylP2 aggregates
formed at pH 5.0, which reaffirmed that these aggregates
possessed fibril-like properties. Thus, the results of both dye
binding assays confirmed that HylP2 forms amyloid-like
fibrils at pH 5.0.
Microscopic Assessment of AggregateMorphology—Themor-
phological features of HylP2 as fibrils at pH 5.0 were unambig-
uously confirmed by electron microscopy and fluorescence
FIGURE2.Structuralchanges inHylP2at25 °CasafunctionofpH.A,changes
inellipticityat218nm(E) andtryptophan fluorescenceemissionwavelength (F)
of recombinantHylP2with change inpH.B,pH-dependent changes inANS fluo-
rescence intensity on binding toHylP2. Inset shows the changes in theANS fluo-
rescence spectra at of HylP2 at pH 5.0 (solid line) and pH 7.0 (dashed line). C, size-
exclusion chromatographic profiles forHylP2 on Superdex 200HR columnat pH
7.0 and pH 5.0 at 25 °C. The column was calibrated with standard molecular
weight markers, glucose oxidase (160 kDa), albumin (66 kDa), ovalbumin (43
kDa), and ribonuclease (13.7 kDa). D, 10% SDS-PAGE profile of glutaraldehyde
cross-linked formofHylP2atpH5.0.Lane1 representsmolecularweightmarkers;
lanes 2 and 3 represent uncross-linked native HylP2 and glutaraldehyde cross-
linked formof HylP2 at pH 5.0, respectively.
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microscopy (Fig. 3C). The fluorescence micrographs of HylP2
showed elongated and unbranched filamentous structure
placed symmetrically like veins of a leaf. The fibers were then
seen to self-assemble into ordered arrays and form amembrane
or film in a fluorescence micrograph. Time-dependent analysis
of the dialyzed samples of HylP2 at pH 5.0 showed that samples
collected in the lag phase of fibril formation showed no ThT
binding in fluorescence micrographs, whereas the log phase
was marked with the appearance of symmetrically and parallel
placed fibers of HylP2. The fluorescence micrographs of HylP2
at the end of log phase demonstrated a thin crumbled mem-
brane-like appearance. The negatively stained electron micro-
scope images of HylP2 also showed a sheet-like feature under
similar conditions, which was similar to a synthetic nanofilm
(32) or to thin film formed by proteins like squid reflectin (33)
or amelogenin (34). No fibrils were detected in HylP2 samples
at pH 7.0.
Kinetics of Fibril Formation in HylP2 Stabilized at pH 5.0
To demonstrate that it is the partially unfolded intermediate
of HylP2 stabilized at pH 5.0 that undergoes fibril formation as
a function of time, we carried out time-dependent binding
studies with ThT and ANS. Changes in the ThT fluorescence
emission at 480 nm as a function of time on binding to HylP2 at
pH 5.0 is shown in Fig. 4A. The increase in ThT fluorescence
intensity followed a sigmoidal pattern that can be distinctly
described in three regions. The initial region of 4 h showed no
change in the fluorescence intensity and signified the nucle-
ation or the lag phase. This was followed by the log phase that
corresponded to the elongation of the fibrils as demonstrated
by a sharp enhancement (about 400 times) for the next 6 h. The
final plateau region of the curve reflected the maturation phase
FIGURE 3. Fibrillation in HylP2. A, binding of Congo red to HylP2. A red shift
of10nm in the absorptionmaximumof thedyewasobservedwithHylP2 at
pH 5.0 as compared with HylP2 at pH 7.0. B, effect of binding of ThT to HylP2
on the fluorescence spectra of the dye. An enhancement (10-fold) in fluores-
cence intensity was observed for HylP2 at pH 5.0 as compared with the pro-
tein at pH 7.0. C, fluorescence and electron micrographs of HylP2. Panel 1,
fluorescencemicrographofHylP2duringdialysis at pH5.0, 0 h;panel 2, 3 h, both
imagesshownofluorescenceandhenceno fibrillar structure;panel36h;panel4,
10h, the imageshowsparallel arrangementof filamentousstructures thatdonot
appearas individual fibers;panel 5, 12h; andpanel 6, 16h, total internal reflection
fluorescence micrograph showing the presence of a thin film of HylP2. Arrows
show the folds in this film. Panels 7 and 8, electronmicrographofHylP2 at pH5.0
showing sheet likemorphology; panel 9, HylP2 at pH 7.0.
FIGURE 4. Kinetics of ThT and ANS binding during fibril formation in
HylP2.A, kinetics of fibrillationpathway forHylP2 asmonitoredby changes in
ThT fluorescence intensity (E) and light scattering at 600 nm (F) with time.
Changes in ThT fluorescence intensity () of HylP2 seeded with HylP2 fibrils
are shown. Error bars indicate the means	 S.E. for all values of ThT binding
evident from triplicatemeasurements. B, characterization of protein interme-
diate involved in fibrillation by ANS fluorescence. Changes in the ANS fluo-
rescence intensity at 465 nm (E) and in the wavelength emission maxima of
ANS (F) with time. Error bars indicate the means	 S.E. for all values of ANS
binding evident from triplicate measurements.
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of HylP2 fibril formation. Formation of HylP2 fibrils seeded
with preformed HylP2 fibrils was also analyzed, and it was seen
that seeding the fibrillation process decreases the lag phase to
3 h as compared with unseeded fibril formation.
The kinetic profile ofANSbinding toHylP2 during dialysis at
pH 5.0 is shown in Fig. 4B. A blue shift in the emission maxima
of ANS fluorescence was seen between 1 and 4 h, which indi-
cated that during this period the protein underwent structural
changes causing the appearance of solvent-exposed hydropho-
bic regions in the protein. The formation of this partially folded
intermediate species was saturated after 4 h of dialysis. An
enhancement in the ANS fluorescence intensity at 465 nm after
4 h indicated an increase in the population of this partially
folded stabilized intermediate ofHylP2. The combined result of
the sigmoidal enhancement of both ANS and ThT binding
curves showed that with the enhancement in the population of
a partially folded intermediate of HylP2 stabilized at pH 5, the
population of the aggregated species was enhanced. Hence,
these results explicitly demonstrated that it was the pH 5.0 sta-
bilized partially unfolded species ofHylP2 that seeded the fibril-
lation process in HylP2.
Characterizationof theCoreDomain inFibrillar FormofHylP2
The key questions regarding the analysis of the nucleation
center in HylP2 fibrils were as follows. First, is the innate
domain organization in native HylP2 also conserved in the
fibrillar structure of HylP2? Second, which of the structural
domains of the enzyme is the core domain in the fibrillation of
HylP2?
Protease Sensitivity of the Fibril
Recently, limited proteolysis has been exploited successfully
for a number of amyloidogenic proteins, including A peptide,
-synuclein, Ure2p, and bovine -lactalbumin to analyze por-
tions of the enzyme structure that are involved in fibril forma-
tion (35–37). The rationale behind this approach is that proteo-
lytic cleavage generally occurs at flexible regions of the
polypeptide chain devoid of hydrogen-bonded regular second-
ary structures such as -helices and -strands. Because there
are about 20 cleavage sites for-chymotrypsin spread through-
out the length of the amino acid sequence of HylP2, we there-
fore used this serine protease for carrying out the limited pro-
teolysis studies. The fibrils of HylP2 at pH 5.0 and native HylP2
at pH 7.0 were incubated for 2 h at 25 °C with -chymotrypsin
in a protein to protease ratio of 500:1, and the proteolyzed sam-
ples were analyzed on a 12% SDS-PAGE as shown in Fig. 5A.
The fragmentation profiles of fibrils of HylP2 and native HylP2
were similar, and in both cases the protein was proteolyzed into
two major protein fragments of 25 and 14 kDa, which corre-
sponded to the C- and N-terminal domains respectively, of the
protein as established earlier (20). To examine the minimum
core portion of the protein involved in fibrillation, we further
performed a cleavage of the fibrillar form ofHylP2 as well as the
native HylP2 with proteinase K. Proteinase K has been used for
a number of other amyloid proteins for carrying out cleavage as
it is a nonspecific protease and cleaves a protein at all noncom-
pact flexible regions. We used the same protein and protease
concentrations for both HylP2 at pH 7.0 and pH 5.0. On exam-
ining the proteolyzed samples on the SDS-PAGE (Fig. 5B), it
was seen that although the native HylP2 was exhaustively
chopped into smaller fragments, the fibril of HylP2 at pH 5.0
was proteolyzed into a lower molecular weight species corre-
sponding to amolecularmass of about 25 kDa. This fragment in
the HylP2 fibril was obtained consistently at both low and high
protease concentrations suggesting that it was very compact
and protease-resistant. We hypothesized that this fragment
resistant to proteolysismight correspond to either theN- or the
C-terminal portion in the fibrillar form of HylP2. Hence, we
carried out N-terminal sequencing of the fragment. The amino
acids obtained from sequencing of this fragment corresponded
to the amino acids (SSSTGGAVN) from residue 127 of the full-
length HylP2. The sequencing reports confirmed that this pro-
tease-resistant fragment belonged to the C-terminal domain of
HylP2. A further conformation of the aforesaid result came
from the Western blot analysis of the fragment obtained on
proteolysis. The fragment was found to possess affinity for anti-
His antibody on Western blot analysis (Fig. 5C), thereby dem-
onstrating that this fragment contains theC-terminalHis6moi-
eties. Because in the recombinant HylP2 protein the histidine
tag was present at the C terminus, this fragment corresponded
to the C-terminal portion of the protein. The proteolysis stud-
ies demonstrated that the domain organization in HylP2
FIGURE 5. SDS-PAGE profile and Western blot of proteolysis of fibrillar
film of HylP2. A, lane 1 represents molecular weight markers; lanes 2 and 4
represent unproteolyzed native and fibrillar form of HylP2, respectively; and
lanes 3 and 5 show thenative and the fibrillar formsofHylP2proteolyzedwith
-chymotrypsin, respectively. B, lane 1 representsmolecular weightmarkers;
lanes 2–4 represent native HylP2 proteolyzed with proteinase K at 1:100 pro-
tease to protein concentration. Lanes 5–7 represent fibrillar of HylP2 proteo-
lyzed with proteinase K at 1:100 at protease to protein ratio for 2, 4, and 6 h,
respectively. C, Western blot of proteolyzed fragment of fibrillar form of
HylP2. Lanes 2 and 3 represent proteolyzed fragment of fibrillar form of HylP2
with-chymotrypsin andproteinaseK, respectively. Lane 1 represents unpro-
teolyzedHylP2 as positive control.D, kinetics of fibrillation pathway for HylP2
as monitored by changes in ThT fluorescence intensity. F, full-length HylP2;
E, N-C-terminal domains (NCcomplex) ofHylP2; andfC-terminal domain
of HylP2 at pH 5.0.
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remained intact during structural transition from native to
fibrillar formofHylP2, and theC-terminal domainwas the core
domain of the fibrillar structure ofHylP2.With the aim to iden-
tify that whether the removal of theN-terminal domain leads to
a disintegration/destabilization of the fibrillar structure of the
protein, we carried out ThT binding and analysis of the film-
like structure through fluorescence electron microscopy of the
residual protease-resistant fragment. Fluorescence emission
intensity centered at 480nmwas similar to that observed for the
unproteolyzed fibrillar form of HylP2 at pH 5.0, and the
digested fibrils when analyzed by fluorescence electronmicros-
copy showed morphology quite similar to that of the undi-
gested fibrils (data not shown). Hence, this indicates that the
N-terminal domain is required for the acquisition of the fibril
state by the protein, and once acquired the fibrillar structure
does not disintegrate even after the removal of the N-terminal
domain from HylP2.
N-terminal Domain of HylP2Modulates the Kinetics of
Fibrillation
As reported earlier, limited proteolysis of the native, fully
foldedHylP2with-chymotrypsin in a protein to protease ratio
of 100:1 yielded the C-terminal domain (20). The C-terminal
domainwas purified by affinity chromatography using a nickel-
nitrilotriacetic acid column. We conducted time-dependent
ThT binding to the isolatedC-terminal domain and assessed its
propensity to form amyloid fibrils under these conditions. For
this the purified C-terminal domain was also dialyzed against
the buffer promoting fibril formation of the native HylP2.
Despite using a similar concentration of theC-terminal domain
as the native protein, fibril formation was not observed under
conditions used for fibrillation of native HylP2 (Fig. 5D). Fibril
formation was also followed using both the N- and C-terminal
domains present together after proteolysis of the full-length
protein. The N-terminal domain of HylP2 is known to hydro-
phobically cling to the C-terminal domain when present
together forming the NC complex of HylP2 (20). The kinetics
of fibrillation of theNCcomplex ofHylP2was analyzed byThT
fluorescence as shown in Fig. 5D. A sigmoidal curve was
obtained for ThT binding to NC complex of HylP2, which was
similar to that obtained with full-length protein at pH 5.0. As
demonstrated, the difference in the two kinetic graphs lies in
presence of a longer lag phase (8 h) in theNCcomplex ofHylP2
as compared with full-length HylP2 at pH 5.0. This demon-
strated that the N-terminal domain of HylP2 was essential for
both the formation as well as the acceleration of fibrillation of
HylP2.
Enzymatic Activity of the Fibrillar Film of HylP2
Enzymatic activity is the unquestionable signature for a pro-
tein having defined natively folded structure. Formation of
fibrils in HylP2 was not accompanied by major changes in the
native domain organization and conformation. Hence, we
explored the presence of enzymatic activity in the pre-fibrillar
intermediate and the mature fibrils of HylP2. Activity was
examined with the specific substrate hyaluronic acid and the
nonspecific substrate chondroitin sulfate for HylP2 (Fig. 6A).
After 1 h, at the end of lag (4 h) and log (15 h) phases of ThT
binding curves, the protein was found to possess 75, 73, and
68% enzymatic activity, respectively, with hyaluronic acid as
compared with that observed for HylP2 at pH 7.0, 0 h (100%
enzymatic activity of native protein). The observed minimal
decrease in the enzymatic activitywith transformation of native
HylP2 into its fibrillar form was in accordance to the minimal
perturbations observed (at N terminus) in its native configura-
tion. Enzymatic activity observed in the fibril form of HylP2
obtained at the end of the exponential decay in theThTbinding
curves was about 20% with chondroitin sulfate as its substrate
withmaximumactivity obtained at low substrate concentration
(0.02 mg/ml with chondroitin sulfate, Fig. 6C) as compared
with nativeHylP2 at pH 7.0 (0.3mg/ml). Fibrillar form ofHylP2
was found to show high substrate inhibition with saturating
concentration of substrate as 0.15 mg/ml of hyaluronic acid
(Fig. 6B). Previous studies have shown that isolated C-terminal
domain of the protein showed activity with both hyaluronic
acid and chondroitin sulfate (20), and similar observationswere
made with the fibrillar structure. Similar to the isolated C-ter-
minal domain, the fibrillar form of HylP2 was also observed to
follow the property of “high substrate inhibition” for both HA
and CS (Fig. 6, B and C). The commonality of this property
supported the fact that the C-terminal domain was the integral
part of the fibrillar film, whereas the N-terminal domain was
unfolded forming a quasi-native form of HylP2 that led the
fibrillation process. There can be two conceivable reasons for
the activity in the fibrillar form of HylP2. First, whether the
activity measured for the dialyzed protein solution was
accounted for mainly by the aggregated species or a fraction of
soluble protein that might possibly have been present in the
assay mixture. To rule out the presence of leftover soluble pro-
tein in the samples, the dialyzed solution ofHylP2 at pH 5.0 was
then ultracentrifuged, and activity was measured only in the
redissolved pellet. Second, if the fibrillar form of HylP2 is prone
to breaking/disintegration on redissolving, it can cause a
decrease in enzymatic activity of the protein in fibrillar form as
compared with native HylP2. To rule out this possibility, the
redissolved samples were checked by ThT binding and fluores-
cence micrographs. Indeed, the ThT binding property and
morphology of amyloid fibrils of HylP2 before and after redis-
solving were similar, pointing toward the fact that once formed
these fibrils are not prone to breaking (Fig. 6D). Kinetics of
substrate degradation was then performed on the redissolved
pellet, and the presence of activity in the sample showed that
the fibrillar form of HylP2 contained native-like functional
units. The residual activity in amyloid form of HylP2 followed a
similar substrate degradation pattern (Fig. 6, B andC) as that of
the isolated C-terminal domain of HylP2 (20).
The structural changes in HylP2 as a function of pH lead to
the formation of an enzymatically active fibrillar film, which
has been schematically illustrated in Fig. 7. This study
strengthened the view that formation of mature fibrils is not
always accompanied by loss of biological function in pro-
teins, instead changes in the enzymatic activity depend on
the extent of changes in the native structure of the fibril-
forming protein.
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Conclusion
The results outlined above demonstrated that the full-length
HylP2 and the N-  C-terminal domain of HylP2 can form
fibrils in vitro over a pH range of 3.0–5.0 on a time scale com-
mensuratewith biophysicalmeasurements. Limited proteolysis
revealed that the domain organization is conserved in HylP2
even after the structural transition because of change in pH, and
that the N-terminal domain affects the rate of fibril formation.
Once formed, complete cleavage and removal of the N-termi-
nal domain do not destabilize the fibrillar structure. TheN- and
C-terminal domains present together form fibrils but with
delayed kinetics as compared with the native unproteolyzed
HylP2, whereas the C-terminal domain alone cannot aggregate
into fibrillar structures. The limited proteolysis data allowed us
to speculate that the C-terminal domain is the minimal com-
pact structure of the fibril of HylP2 protein and was not found
to be digested even after prolonged digestion with the protease.
This result is in accord with the finding that fibrils are usually
resistant to proteolysis (38–41) and structurally consist of sev-
eral twisted filamentous units of protein (41, 42). Hence, the
proteinmolecules lying within the twistedmorphology of these
proto-filaments are not accessible to any protease, as the C-ter-
minal domain of HylP2 in this case. The C-terminal domain
does not contain the fibrillar core, as the isolated C-terminal
domain is not seen to form amyloid film under similar experi-
mental conditions as the full-length protein. But the active site
of HylP2 lies at the C-terminal domain (20). Despite the fact
that the active site is located at theC-terminal domain ofHylP2,
it shows 70% activity with its substrate hyaluronic acid, which
can be due to the unfolding of the N-terminal domain of HylP2
during the formation of fibrillar film (Fig. 7). It also suggests
that the entire sequence of the proteinmolecule is not incorpo-
FIGURE 6. Enzymatic activity profile of native and fibril forms of HylP2.
A, activity in native and fibrillar film of HylP2 with HA and CS as substrate for
the enzyme. Percentage activity of full-length native HylP2 at pH 7.0 with
hyaluronan as its substrate is considered to be 100%. The bars indicate the
following: bar 1, HylP2 at pH 7.0; bar 2, HylP2 at pH 5.0 (1 h); bar 3, HylP2 at pH
5.0 after 4 h; bar 4, fibrillar formofHylP2 at pH5.0; bar 5, after 16 h. Percentage
activity of full-length HylP2 in its fibrillar film state at pH 5.0 after 14 h with
chondroitin sulfate as substrate. Bars 6 and 7 represent percentage activity of
isolated C-terminal domain of HylP2 at pH 7.0 with hyaluronic acid and chon-
droitin sulfate, respectively. Residual activity is 11%, which is similar to resid-
ual percent activity in the mature fibrillar film form of HylP2 at pH 5.0 for
chondroitin sulfate. Error bars represent means 	 S.E. averaged from
velocity measurements taken at saturating substrate concentrations with
triplicate samples. B and C, data points represent “High substrate inhibi-
tion” pattern of substrate degradation followed by fibrillar film of HylP2
for hyaluronan and chondroitin sulfate, respectively. The error bars repre-
sent 	 % error obtained in absorbance values at 232 nm obtained from
triplicate samples. D, fluorescence micrographs of HylP2. Panel 1, HylP2 at
1 mg/ml concentration after 14 h of dialysis into CGH buffer at pH 5.0. The
micrograph represents a film or ribbon-like morphology on staining with
ThT. Panel 2, HylP2 at 1 mg/ml and dialyzed for over 14 h was then ultra-
centrifuged at 80,000 rpm for 2 h. A glossy pellet was obtained and redis-
solved in CGH buffer (pH 5.0). Fluorescence microscope images were ana-
lyzed by methods described under “Fluorescence Microscopy.” The
images resembled each other in the presence of a similar film-like mor-
phological structure of HylP2. Hence, redissolving did not break the fibril-
lar film of HylP2.
FIGURE 7. Schematic representation of the fibrillation pathway in HylP2.
The scheme shows that lowering the pH of HylP2 from 7.0 to 5.0 leads to
partial unfolding of the N-terminal domain while the trimeric C-terminal
domain remains unaltered. Formation of this intermediate species is the crit-
ical event leading to formation of higher order aggregates of HylP2. The par-
tially unfolded HylP2 molecules then associate together to form highmolec-
ularweight aggregates, which showdyebindingproperties andANSbinding
properties. These filamentous/fibrillar units later collapse into an ordered
array and appear as a thin film.
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rated in the fibrillar core structure and is well supported by
earlier studies made on Tau protein and -synuclein (35, 43).
To date, fibril formation has not been studied in the hyalu-
ronidase family of proteins. The conclusion that fibril forma-
tion in the bacteriophage hyaluronidase occurs as a function of
pH and begins at a pH value of 5.0, which is very close to the pH
of maximal activity of the protein (pH 6.2), is interesting
because such a phenomenon in vivo could be expected to occur
during the intermediacy of the phage hyaluronate lyasewith the
acidic extracellular bacterial matrix. Bacteriophage is a promi-
nent source of transferring virulent genes to bacteria; hence,
functionality inHylP2 over a wide range of pH and resistance to
pH appears to be essential for phage infection. Because chon-
droitin sulfate is present only inmammalian connective tissues,
the acquisition of enzymatic activity toward chondroitin sulfate
by HylP2 also suggests that the enzyme of this temperate bac-
teriophage might assist in the bacterial invasion of host tissue,
and therefore it serves as an adaptation for the bacterium as
well as for the phage. Thus, our investigation illustrates the
diversity of fibrillar function across genomes and demands the
need to study its occurrence.
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